Michael C. Meyer

1.3k total citations
41 papers, 662 citations indexed

About

Michael C. Meyer is a scholar working on Management, Monitoring, Policy and Law, Demography and Anthropology. According to data from OpenAlex, Michael C. Meyer has authored 41 papers receiving a total of 662 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Management, Monitoring, Policy and Law, 7 papers in Demography and 6 papers in Anthropology. Recurrent topics in Michael C. Meyer's work include Historical Studies in Latin America (7 papers), Archaeology and Natural History (6 papers) and Mexican Socioeconomic and Environmental Dynamics (6 papers). Michael C. Meyer is often cited by papers focused on Historical Studies in Latin America (7 papers), Archaeology and Natural History (6 papers) and Mexican Socioeconomic and Environmental Dynamics (6 papers). Michael C. Meyer collaborates with scholars based in United States, Germany and Austria. Michael C. Meyer's co-authors include John Womack, James W. Wilkie, G. Wolff, Terry McLendon, Clifton B. Kroeber, Rainer N. Zahlten, Jutta Beier, David L. Price, Kai Michael Beeh and Roland Buhl and has published in prestigious journals such as Journal of Clinical Oncology, Blood and FEBS Letters.

In The Last Decade

Michael C. Meyer

37 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael C. Meyer United States 14 134 110 77 75 62 41 662
Kenneth McPherson Australia 7 43 0.3× 78 0.7× 94 1.2× 29 0.4× 112 1.8× 26 606
Peter Evans United Kingdom 13 112 0.8× 131 1.2× 26 0.3× 110 1.5× 116 1.9× 27 872
John Middleton United Kingdom 15 55 0.4× 113 1.0× 91 1.2× 10 0.1× 12 0.2× 67 663
Mary Young United States 9 23 0.2× 65 0.6× 110 1.4× 36 0.5× 36 0.6× 35 437
R. Cole Harris United Kingdom 11 15 0.1× 76 0.7× 119 1.5× 6 0.1× 47 0.8× 21 756
Peter Sutherland Australia 16 111 0.8× 91 0.8× 227 2.9× 6 0.1× 21 0.3× 53 961
Gary W. Gallagher United States 11 79 0.6× 100 0.9× 131 1.7× 12 0.2× 10 0.2× 63 567
J. Andrew Grant Canada 17 80 0.6× 204 1.9× 44 0.6× 210 2.8× 151 2.4× 55 899
Jin Satō Japan 13 61 0.5× 88 0.8× 76 1.0× 5 0.1× 15 0.2× 71 725
T. Lynn Smith United States 14 17 0.1× 61 0.6× 395 5.1× 6 0.1× 41 0.7× 47 1.0k

Countries citing papers authored by Michael C. Meyer

Since Specialization
Citations

This map shows the geographic impact of Michael C. Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael C. Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael C. Meyer more than expected).

Fields of papers citing papers by Michael C. Meyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael C. Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael C. Meyer. The network helps show where Michael C. Meyer may publish in the future.

Co-authorship network of co-authors of Michael C. Meyer

This figure shows the co-authorship network connecting the top 25 collaborators of Michael C. Meyer. A scholar is included among the top collaborators of Michael C. Meyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael C. Meyer. Michael C. Meyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schwedt, Todd J., Tina M. Oakes, James M. Martinez, et al.. (2023). Comparing the Efficacy and Safety of Galcanezumab Versus Rimegepant for Prevention of Episodic Migraine: Results from a Randomized, Controlled Clinical Trial. Neurology and Therapy. 13(1). 85–105. 19 indexed citations
2.
Pleimes, Dirk, et al.. (2018). Effects of a Novel Orally Bioavailable Small Molecule (Imidazolyl Ethanamide Pentandioic Acid) on Acute Radiation Syndrome. Blood. 132(Supplement 1). 5089–5089. 1 indexed citations
3.
Pleimes, Dirk, et al.. (2014). Effect of IEPA, a Novel Orally Bioavailable Small Molecule, on Chemotherapy-Induced Myelosuppression. Blood. 124(21). 4355–4355. 1 indexed citations
4.
Watz, Henrik, Daniel Bock, Michael C. Meyer, et al.. (2012). Inhaled pan-selectin antagonist Bimosiamose attenuates airway inflammation in COPD. Pulmonary Pharmacology & Therapeutics. 26(2). 265–270. 42 indexed citations
5.
Watz, Henrik, Daniel Bock, Michael C. Meyer, et al.. (2011). Late-breaking abstract: Inhaled pan-selectin antagonist bimosiamose in COPD: A double-blind, randomized, placebo-controlled phase II study. European Respiratory Journal. 38(Suppl 55). 4492–4492. 2 indexed citations
6.
Mayr, Florian, Christa Firbas, Judith Leitner, et al.. (2008). EFFECTS OF THE PAN-SELECTIN ANTAGONIST BIMOSIAMOSE (TBC1269) IN EXPERIMENTAL HUMAN ENDOTOXEMIA. Shock. 29(4). 475–482. 10 indexed citations
7.
Meyer, Michael C., et al.. (2007). The pharmacokinetics of subcutaneously injected bimosiamose disodium in healthy male volunteers. Biopharmaceutics & Drug Disposition. 28(9). 475–484. 4 indexed citations
8.
Meyer, Michael C., Kai Michael Beeh, Jutta Beier, et al.. (2006). Tolerability and pharmacokinetics of inhaled bimosiamose disodium in healthy males. British Journal of Clinical Pharmacology. 63(4). 451–458. 7 indexed citations
9.
Levine, Robert L., S. C. Lowry, Jean-François Dhainaut, et al.. (2005). THE SAFETY OF DROTRECOGIN ALFA (ACTIVATED): INDEPTH DATA ANALYSIS SUGGESTS SURVIVAL BENEFIT INDEPENDENT OF SERIOUS ADVERSE EVENT OCCURRENCES. CHEST Journal. 128(4). 221S–221S. 1 indexed citations
10.
Meyer, Michael C., Bernd Jilma, Rainer N. Zahlten, & G. Wolff. (2005). Physiochemical properties, safety and pharmacokinetics of bimosiamose disodium after intravenous administration. International Journal of Clinical Pharmacology and Therapeutics. 43(10). 463–471. 9 indexed citations
11.
12.
Flüge, Thomas, G Kunkel, Barbara Schneider, et al.. (1999). Bronchodilation using combined urodilatin - albuterol administration in asthma: a randomized, double-blind, placebo-controlled trial.. PubMed. 4(10). 411–5. 7 indexed citations
13.
Meyer, Michael C.. (1997). El agua en el suroeste hispánico: una historia social y legal 1550-1850.
14.
Kroeber, Clifton B. & Michael C. Meyer. (1985). Water in the Hispanic Southwest: A Social and Legal History, 1550-1850. The American Historical Review. 90(2). 520–520. 41 indexed citations
15.
Meyer, Michael C. & Linda B. Hall. (1982). Alvaro Obregon: Power and Revolution in Mexico, 1911-1920. The American Historical Review. 87(3). 887–887. 2 indexed citations
16.
Maciel, David R., Michael C. Meyer, & William R. Sherman. (1979). The Course of Mexican History. The History Teacher. 13(1). 131–131. 18 indexed citations
17.
Calvert, Peter, et al.. (1977). Contemporary Mexico: Papers of the IV International Congress of Mexican History.. Hispanic American Historical Review. 57(3). 520–520. 4 indexed citations
18.
Meyer, Michael C., et al.. (1973). Huerta: A Political Portrait.. Hispanic American Historical Review. 53(3). 519–519. 5 indexed citations
19.
Meyer, Michael C., et al.. (1970). Zapata: The Ideology of a Peasant Revolutionary.. Hispanic American Historical Review. 50(1). 157–157. 1 indexed citations
20.
Meyer, Michael C.. (1969). Zapata and the Mexican Revolution. Hispanic American Historical Review. 49(4). 775–777. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026